Cargando…
Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor
Epilepsy is one of the most common chronic diseases of the central nervous system (CNS). Treatment of epilepsy remains, however, a clinical challenge with over 30% of patients not responding to current pharmacological interventions. Complicating management of treatment, epilepsy comes with multiple...
Autores principales: | Gil, Beatriz, Smith, Jonathon, Tang, Yong, Illes, Peter, Engel, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875404/ https://www.ncbi.nlm.nih.gov/pubmed/35216493 http://dx.doi.org/10.3390/ijms23042380 |
Ejemplares similares
-
The P2X7 Receptor as a Mechanistic Biomarker for Epilepsy
por: Engel, Tobias
Publicado: (2023) -
Inherent P2X7 Receptors Regulate Macrophage Functions during Inflammatory Diseases
por: Ren, Wenjing, et al.
Publicado: (2021) -
Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy
por: Engel, Tobias, et al.
Publicado: (2021) -
Neonatal Seizures and Purinergic Signalling
por: Menéndez Méndez, Aida, et al.
Publicado: (2020) -
The ATP-Gated P2X7 Receptor As a Target for the Treatment of Drug-Resistant Epilepsy
por: Beamer, Edward, et al.
Publicado: (2017)